NewcelX Ltd. (NCEL)

NASDAQ

$2.59

$-0.16

(-5.79%)

Regular Market

NewcelX Ltd. (NCEL) Live Price Chart

Last updated: ⁦2026-10-28 19:17:00⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

NewcelX Ltd. (NCEL) operates in the -- sector and is listed on NASDAQ. The stock is currently priced at $2.59, with a market capitalization of $14.73M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.83 to $7.64. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$14.73M
Open	$2.75
Day's High	$7.64
Day's Low	$1.83
Previous Close	$2.74
Volume	2.76K
Average Volume	8.76K
P/E Ratio	--
52-Week High	$7.64
52-Week Low	$1.83
Dividend Yield	--
Earnings Date	--

NewcelX Ltd. (NCEL) Stock Price Today

NewcelX Ltd. (NCEL) is currently trading at $2.59 as of 2026-10-28 18:57:00, down 5.62% ($0.15) from the previous close of $2.74

During today's regular trading session, NCEL has traded between $1.83 and $7.64, with a trading volume of 2.76K shares. The current price is near the lower end of today's range.

NewcelX Ltd. (NCEL) 7-Day Stock Price Change

Over the past seven days, NewcelX Ltd. (NCEL) moved from $2.63 to $2.59, representing a decline of 1.67% ($0.04).

The stock traded between $2.36 and $3.04 during the period. The latest price is near the middle of the 7-day range, indicating moderate downward.

The average daily volume was 11.15 thousand shares, up versus the previous seven-day period, indicating higher trading activity.

NCEL 52-Week Price Position

Position in Range: 13.0%

52W Low$1.83

52W High$7.64

NCEL is currently trading at $2.59, placing it 13.0% of the way from its 52-week low of $1.83 to its 52-week high of $7.64. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is NewcelX Ltd. (NCEL)?

NewcelX Ltd is a clinical-stage biopharmaceutical company focused on developing transformative therapies. Built on a validated human pluripotent stem cell (hPSC) platform, the Company's main program, NCEL-101, is designed to restore functional insulin production through scalable, off-the-shelf cell replacement. It is advancing a comprehensive therapeutic approach for Type 1 Diabetes, integrating cell therapy, immune protection, and translational science, including a phase IIa clinical trial for the treatment of Amyotrophic Lateral Sclerosis (ALS) in the field of regenerative medicine, as well as the development of treatments for Central Nervous System (CNS) disorders, including Narcolepsy, utilizing its Doxa platform. Its products are Holistic, IsletRx, AstroRx, and the DOXA platform.

NewcelX Ltd. Information

Employees	4
Exchange	NASDAQ
Company Website	https://www.newcelx.com

How to Buy NewcelX Ltd. (NCEL) Stock on MEXC

Eligible investors can buy real shares of NewcelX Ltd. (NCEL) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for NCEL and Place Your Order

Open the RealStocks trading page and search for NCEL. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is NewcelX Ltd. (NCEL) stock price today?

NewcelX Ltd. (NCEL) is currently trading at $ 2.59, down 5.62% ($0.15) from the previous close of $ 2.74. Intraday prices update in real time during regular trading hours.

2.Is NCEL stock going up or down today?

As of 2026-10-28 18:57:00, NCEL is trading at $ 2.59, down 5.62% ($0.15) from its previous close of $ 2.74. The stock has traded between $ 1.83 and $ 7.64 during today’s regular session. Past price movements do not guarantee future results.

3.What is NCEL pre-market price?

As of 2026-10-28 18:57:00, NCEL is trading at $ 2.75 in pre-market trading, up 0.18% ($0.00) from the previous close of $ 2.74. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is NCEL after-hours price?

As of 2026-10-28 18:57:00, NCEL is trading at $ 2.75 in after-hours trading, up 0.18% ($0.00) from the regular-session close of $ 2.74. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is NCEL stock trading now?

NCEL trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does NCEL sit relative to its 52-week high and low?

Over the past 52 weeks, NCEL has traded between a low of $ 1.83 and a high of $ 7.64. At $ 2.59, the stock is positioned 13.0% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is NewcelX Ltd. in?

NewcelX Ltd. (NCEL) operates in the -- sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is NewcelX Ltd.'s market capitalization and where is it listed?

NewcelX Ltd. is listed on the NASDAQ exchange with a market capitalization of $ 14.73M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is NCEL valued in terms of P/E ratio and EPS?

NCEL trades at a P/E ratio of --, based on trailing-twelve-month EPS of --. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does NewcelX Ltd. pay a dividend?

NewcelX Ltd. pays an indicated annual cash dividend of -- per share, with a current dividend yield of --% based on the latest share price. Dividend policies are subject to change at the board's discretion.